Contract Win & Trading Update

RNS Number : 0106Q

Imaginatik PLC

03 April 2009

 



3 April 2009

Imaginatik Plc

('Imaginatik' or the 'Company')

Contract Win & Trading Update

 

Imaginatik plc (AIM: IMTK), a leading provider of cost reduction, process improvement and collaborative innovation software and processes, is pleased to announce it has signed a significant contract extension with Pfizer, Inc., a long-standing customer of Imaginatik’s and investor in the Company. This contract extension ensures the long term ongoing use of Imaginatik’s Idea Central software within Pfizer’s Research and Development division.

Imaginatik expects to announce Final Results for the year ended 31^st March 2009 in line with market expectations.

Mark Turrell, CEO of Imaginatik plc, commented, 'The past 12 months has been a key period in the development of Imaginatik. It has seen the Company mature into a more stable and well managed business with an increasing ability to secure longer term contracts resulting in much greater certainty in earnings going forward. We are delighted to report that, in line with market expectations, we expect this maturity to translate into a maiden operating profit for the year.' 

For further information please contact:  

Imaginatik plc	Tel: [phone]
Mark Turrell, CEO / Shawn Taylor, CFO
WH Ireland Limited	Tel: [phone]
Tim Cofman / Katy Birkin
ICIS	Tel: [phone]
Caroline Evans-Jones / Mike Smith

About Imaginatik

Imaginatik is the leading provider of cost reduction, process improvement and collaborative innovation software and processes to the world's leading companies. More than 100 clients rely on Imaginatik's software, consulting and research to enable their best-of-breed innovation activities.

Named as a World Economic Forum Technology Pioneer for 2008 and a finalist for the IBM Lotus Awards 2008 in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings, process improvements and increased product pipeline. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as the London Business School and the Cass School of Business, London, as well as leading practitioners of corporate innovation.

For further information please visit www.imaginatik.com

 

END

 

 

CNTSSIFFESUSESL